ÌÇÐÄÆƽâ°æ

Skip to main content

Leading therapy areas in the U.S. by commercial PMPM spending in 2022 (in U.S. dollars)

Leading therapy areas by commercial PMPM spending U.S. 2022

Last update:
Oct 12, 2023
Author:
ÌÇÐÄÆƽâ°æ Research Department
Region:
United States
Survey time period:
From 01/01/2022 to 31/12/2022

Related insights

Change in Medicare PMPM spending in top drug categories 2021-2022
USA
Oncology drug PMPM spending U.S. 2023-2025
USA
Commercial insurance PMPM spending on medical drug claims in the U.S. 2018-2021
USA
Leading medical benefit drugs by commercial PMPM spending U.S. 2022
USA
Change in Medicaid PMPM spending in drug categories 2021-2022
USA
Top therapy spending areas in pharmerging markets 2018
Worldwide
Change in Medicare PMPM spending on medical benefit drugs 2021-2022
USA
Leading specialty therapy areas in the U.S. by PMPY spending 2020
USA
Leading therapy classes by spending global market 2028
Worldwide
Change in Medicaid PMPM spending in top medical benefit drugs 2021-2022
USA
Leading traditional therapy areas in the U.S. by PMPY spending 2020
USA
Asthma/COPD drug PMPM spending U.S. 2019-2024
USA
Medicaid PMPM spending on medical drug claims 2018-2021
USA
Top specialty therapy spending in developed pharmaceutical markets 2020
Worldwide
Medicare PMPM spending on medical drug claims 2018-2021
USA
Leading therapy areas by pharma revenue in the U.S. 2025
USA
Immune globulin drug PMPM spending in U.S. 2022-2025
USA
Predicted oncology spending in 2023, by region
Worldwide
Oncology therapeutic spending growth 2013-2018 U.S. vs pharmerging
Worldwide
Leading traditional therapy areas by Medicare PMPY spending 2020
USA
We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch